Catherine Alix-Panabières, PhD, Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB , Hôpital Saint-Eloi - CHRU Montpellier, France

Emmanuel S. Antonarakis, MD, Professor of Medicine
University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, USA

Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center Feinberg School of Medicine, Chicago, IL, USA

Caroline Dive, PhD, Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

Tanja Fehm, Department of Gynecology and Obstetrics, Heinrich Heine University Duesseldorf, Duesseldorf, Germany

Helen Heitzer, PhD, Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria

Dave Hoon, PhD, Director Translational Molecular Medicine, SJCI PHS, Santa Monica CA, USA

Michail Ignatiadis, MD. PhD, Assoc. Professor, Université Libre de Bruxelles, Jules Bordet Institute Brussels, Belgium, Chair Breast Cancer Group EORTC

Wolfgang Janni, MD PhD
Medical Director of the Gynaecological University Hospital Ulm, University of Ulm, Germany

Sabine Kasimir-Bauer, PhD
Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany

Evi Lianidou, PhD
Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

Klaus Pantel, MD, PhD
Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

Nicholas Papadopoulos, PhD, Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA

Jean-Yves Pierga, MD, PhD, Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France

Amanda Psyrri, MD, PhD, Professor, University of Athens Medical School, Attikon University Hospital, Athens, Greece

Christian Rolfo, MD, PhD, MBA, Dr.hc., Professor and Assoc. Director for Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York,  USA

Howard Scher, MD, Medical Oncologist, Co-Chair, Center for Mechanism Based Therapy; Head of the Biomarker Development Initiative; D. Wayne Calloway Chair in Urologic Oncology, Memorial Sloan Kettering Cancer Research, New York, NY, USA

María Jose Serrano Fernández, PhD, Scientific Director of Liquid Biopsies Division, Liquid Biopsies & Cancer Interception group, GENyO Centre/ Hospital Virgen de las Nieves, Granada, Spain

Michael Speicher, MD, Institute of Human Genetics, Medical University of Graz, Austria

Nikolas Stoecklein, MD, Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany